DUCHESNAY USA, INC.
PRINCETON, NJ

Duchesnay USA, Inc. is a specialty pharmaceutical company dedicated to advancing women's health across all stages of life, particularly focusing on maternal-fetal medicine and conditions such as nausea and vomiting of pregnancy (NVP). Originally established in Canada as a family-owned enterprise, Duchesnay shifted its emphasis toward developing medications safe for use during pregnancy after personal experiences highlighted significant gaps in treatment availability. Established in the United States to extend these innovative treatments to American women, Ducnesnay USA operates from Princeton, Broward County, Florida. The company's commitment extends beyond maternal care into broader therapeutic areas that address diverse health and quality of life needs for women at various life stages, continuously innovating to enhance treatment options. Operating under stringent compliance with laws and regulations, Duchesnay values safety, quality, and effectiveness as its top priorities which underlies all operations. With investments in research and development, Duchesnay partners with academia and supports various perinatal health initiatives. Additionally, it contributes to community well-being through involvement with organizations like The Autism Society of Greater Philadelphia and ensures educational outreach for both professionals and the public. Founded on the principle of improving women's health outcomes, Duchesnay USA retains a strong commitment to ongoing pharmaceutical research and the provision of safe medical solutions. Duchesnay’s registered office is located at 950 Michele-Bohec Blvd, Blainville, QC, Canada, with additional contact points across various locations. As of its incorporation on January 23, 2013, it holds Florida company status and is led by executives like Tanya Carro among others. The latest annual report was filed as of April 29, 2024. For more information about their products and initiatives, visit Duchesnay USA at duchesnayusa.com.